Asthma a chronic respiratory condition may be driven by specific immune cells that influence inflammation and severity ...

Initially developed for atopic dermatitis, Enveda's lead asset ENV-294 is now showing promise in treating asthma.

This article will review the pathophysiology of asthma, the physiologic changes in pregnancy, the determinants of fetal oxygenation, and options for appropriate and effective medical management ...

Airway inflammation is a critical feature in the pathogenesis of asthma. Clinical investigation and testing are done to diagnose the disease and to identify the offending exposure. Testing ...

The leading Severe Asthma Companies such as Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology, AB Science, GlaxoSmithKline, Oneness Biotech, Biosion, Lanier ...

The use of digital twins with industrial, manufacturing and architectural use cases is well known, and in the manifold ...

New classes of drug are based on a better understanding of the complex pathophysiology of asthma and include inhibitors of specific mediators, cytokines and chemokines. Several new classes of drug ...

Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the acceptance of its Investigational New Drug (IND) application by the China National Medical Products Administration (NMPA) ...

KEY POINTS Chronic rhinosinusitis refers to symptomatic inflammation of the nose and paranasal sinuses that has been present for a minimum of 3 months.[1][1] Its true prevalence is difficult to ...